Al-Mutairi AA - Search Results

1

In-silico studies to recognize repurposing therapeutics toward arginase-I inhibitors as a potential onco-immunomodulators.

Zaki MEA, Al-Hussain SA, Al-Mutairi AA, Samad A, Ghosh A, Chaudhari S, Khatale PN, Ajmire P, Jawarkar RD. Zaki MEA, et al. Among authors: al mutairi aa. Front Pharmacol. 2023 Apr 18;14:1129997. doi: 10.3389/fphar.2023.1129997. eCollection 2023. Front Pharmacol. 2023. PMID: 37144217 Free PMC article.

2

Mechanistic Analysis of Chemically Diverse Bromodomain-4 Inhibitors Using Balanced QSAR Analysis and Supported by X-ray Resolved Crystal Structures.

Zaki MEA, Al-Hussain SA, Al-Mutairi AA, Masand VH, Samad A, Jawarkar RD. Zaki MEA, et al. Pharmaceuticals (Basel). 2022 Jun 14;15(6):745. doi: 10.3390/ph15060745. Pharmaceuticals (Basel). 2022. PMID: 35745664 Free PMC article.

3

QSAR Evaluations to Unravel the Structural Features in Lysine-Specific Histone Demethylase 1A Inhibitors for Novel Anticancer Lead Development Supported by Molecular Docking, MD Simulation and MMGBSA.

Jawarkar RD, Bakal RL, Mukherjee N, Ghosh A, Zaki MEA, Al-Hussain SA, Al-Mutairi AA, Samad A, Gandhi A, Masand VH. Jawarkar RD, et al. Molecules. 2022 Jul 25;27(15):4758. doi: 10.3390/molecules27154758. Molecules. 2022. PMID: 35897936 Free PMC article.

4

QSAR, Molecular Docking, MD Simulation and MMGBSA Calculations Approaches to Recognize Concealed Pharmacophoric Features Requisite for the Optimization of ALK Tyrosine Kinase Inhibitors as Anticancer Leads.

Jawarkar RD, Sharma P, Jain N, Gandhi A, Mukerjee N, Al-Mutairi AA, Zaki MEA, Al-Hussain SA, Samad A, Masand VH, Ghosh A, Bakal RL. Jawarkar RD, et al. Molecules. 2022 Aug 3;27(15):4951. doi: 10.3390/molecules27154951. Molecules. 2022. PMID: 35956900 Free PMC article.

5

Design, Synthesis and Pharmacological Evaluation of 2-(3-BenzoyI-4-Hydroxy-1,1-Dioxido-2H-Benzo[e][1,2]thiazin-2-yI)-N-(2-Bromophenyl) Acetamide as Antidiabetic Agent.

Rashid F, Ahmad M, Ashfaq UA, Al-Mutairi AA, Al-Hussain SA. Rashid F, et al. Drug Des Devel Ther. 2022 Nov 22;16:4043-4060. doi: 10.2147/DDDT.S379205. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 36444273 Free PMC article.

6

Pharmacophore Synergism in Diverse Scaffold Clinches in Aurora Kinase B.

Masand VH, Al-Hussain SA, Rathore MM, Thakur SD, Akasapu S, Samad A, Al-Mutairi AA, Zaki MEA. Masand VH, et al. Int J Mol Sci. 2022 Nov 22;23(23):14527. doi: 10.3390/ijms232314527. Int J Mol Sci. 2022. PMID: 36498857 Free PMC article.

7

QSAR modeling approaches to identify a novel ACE2 inhibitor that selectively bind with the C and N terminals of the ectodomain.

Jawarkar RD, Zaki MEA, Al-Hussain SA, Al-Mutairi AA, Samad A, Mukerjee N, Ghosh A, Masand VH, Ming LC, Rashid S. Jawarkar RD, et al. Among authors: al mutairi aa. J Biomol Struct Dyn. 2024 Mar;42(5):2550-2569. doi: 10.1080/07391102.2023.2205948. Epub 2023 May 5. J Biomol Struct Dyn. 2024. PMID: 37144753

8

Application of in-silico drug discovery techniques to discover a novel hit for target-specific inhibition of SARS-CoV-2 Mpro's revealed allosteric binding with MAO-B receptor: A theoretical study to find a cure for post-covid neurological disorder.

Zaki MEA, Al-Hussain SA, Al-Mutairi AA, Samad A, Masand VH, Ingle RG, Rathod VD, Gaikwad NM, Rashid S, Khatale PN, Burakale PV, Jawarkar RD. Zaki MEA, et al. Among authors: al mutairi aa. PLoS One. 2024 Jan 16;19(1):e0286848. doi: 10.1371/journal.pone.0286848. eCollection 2024. PLoS One. 2024. PMID: 38227609 Free PMC article.

9

Mechanistic QSAR modeling derived virtual screening, drug repurposing, ADMET and in-vitro evaluation to identify anticancer lead as lysine-specific demethylase 5a inhibitor.

Jawarkar RD, Zaki MEA, Al-Hussain SA, Al-Mutairi AA, Samad A, Masand V, Humane V, Mali S, Alzahrani AYA, Rashid S, Elossaily GM. Jawarkar RD, et al. Among authors: al mutairi aa. J Biomol Struct Dyn. 2024 Feb 22:1-31. doi: 10.1080/07391102.2024.2319104. Online ahead of print. J Biomol Struct Dyn. 2024. PMID: 38385447

10

Natural compounds for oxidative stress and neuroprotection in schizophrenia: composition, mechanisms, and therapeutic potential.

Khan AN, Jawarkar RD, Zaki MEA, Al Mutairi AA. Khan AN, et al. Among authors: al mutairi aa. Nutr Neurosci. 2024 Mar 11:1-15. doi: 10.1080/1028415X.2024.2325233. Online ahead of print. Nutr Neurosci. 2024. PMID: 38462971 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page